Timothy Block
Director/Board Member at HEPION PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Timothy M.
Block is the founder of Hepatitis B Foundation, Baruch S.
Blumberg Institute, Hatch Biofund Management LLC, MERLIN Biotech LLC.
He is currently the President & Chief Executive Officer of Pennsylvania Biotechnology Center of Bucks County, an Independent Director at Hepion Pharmaceuticals, Inc., and a Professor-Microbiology & Immunology at Drexel University College of Medicine.
He was formerly a Director at Glycotest, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-18 | 0 ( -.--% ) | - $ | 2024-03-30 |
Timothy Block active positions
| Companies | Position | Start |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 2013-11-25 |
| Hepatitis B Foundation | Founder | - |
| Drexel University College of Medicine | Corporate Officer/Principal | - |
| Pennsylvania Biotechnology Center of Bucks County | Chief Executive Officer | - |
| Baruch S. Blumberg Institute | Founder | - |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Founder | - |
Former positions of Timothy Block
| Companies | Position | End |
|---|---|---|
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Hepatitis B Foundation | |
| Pennsylvania Biotechnology Center of Bucks County | |
| Baruch S. Blumberg Institute | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Stock Market
- Insiders
- Timothy Block
